Company Filing History:
Years Active: 1995-2002
Title: Russell L Regnery: Innovator in Medical Diagnostics and Therapeutics
Introduction
Russell L Regnery is a notable inventor based in Tucker, GA (US). He has made significant contributions to the field of medical diagnostics and therapeutics, holding a total of 6 patents. His work primarily focuses on developing compositions for diagnosing and protecting against infections caused by specific pathogens.
Latest Patents
Among his latest patents, one notable invention is related to compositions for diagnosing Rochalimaea henselae and Rochalimaea quintana infections. This patent discloses fusion protein compositions containing the sequence of a 17 kilodalton antigenic polypeptide of Rochalimaea, which can be used for diagnosing cat scratch disease and bacillary angiomatosis by detecting antibodies that specifically bind to the polypeptide. Another significant patent involves a composition designed to protect mammals against Bartonella henselae infection. This therapeutic composition includes an isolated B. henselae antigen and an adjuvant comprising a phosphazene polymer. It also outlines a method to protect humans from cat scratch disease by administering the therapeutic composition to domestic cats in contact with them.
Career Highlights
Throughout his career, Russell L Regnery has worked with esteemed organizations, including the United States of America as represented by the Department of Health. His innovative work has contributed to advancements in medical science and public health.
Collaborations
Russell has collaborated with notable individuals in his field, including Burt E Anderson and Jane A Rooney. Their combined expertise has likely enhanced the impact of his inventions.
Conclusion
Russell L Regnery's contributions to medical diagnostics and therapeutics demonstrate his commitment to innovation in healthcare. His patents reflect a dedication to improving the diagnosis and treatment of infectious diseases, showcasing the importance of research and development in this critical field.